Shopping Cart
Remove All
Your shopping cart is currently empty
Setrusumab (BPS 804) is a fully humanized monoclonal antibody targeting sclerostin, effectively enhancing bone strength, used in research on Osteogenesis Imperfecta (OI) and cancer [1].
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $332 | 2-4 weeks | 2-4 weeks | |
| 5 mg | $996 | 2-4 weeks | 2-4 weeks | |
| 10 mg | $1,570 | 2-4 weeks | 2-4 weeks |
| Description | Setrusumab (BPS 804) is a fully humanized monoclonal antibody targeting sclerostin, effectively enhancing bone strength, used in research on Osteogenesis Imperfecta (OI) and cancer [1]. |
| In vivo | Setrusumab, administered at a dosage of 100 mg/kg via intravenous injection once weekly for a duration of four weeks, inhibited bone metastasis and muscle weakness induced by breast cancer in mice [1]. |
| Synonyms | BPS 804 |
| Reactivity | Human |
| Application | FACS Functional assay |
| Antibody Type | Monoclonal |
| Host Species | < 1.0 EU/mg |
| Conjucates | Unconjugated |
| Uniprot ID |
| Cas No. | 1847394-95-9 |
| Storage | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.